Maxcyte (MXCT) Change in Accured Expenses (2020 - 2026)
Maxcyte (MXCT) reported Change in Accured Expenses of -$3.6 million for Q1 2026, down 90825.0% year-over-year from N/an in Q1 2025, and down 210.15% on a QoQ basis from $3.3 million in Q4 2025.
Maxcyte (MXCT) has 7 years of Change in Accured Expenses data on file, last reported at -$3.6 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 90825.0% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 94.85% YoY) and the FY2025 annual result came in at -$36000.0, up 98.09% from the prior year.
- Change in Accured Expenses eased to -$3.6 million in Q1 2026 per MXCT's latest filing, from $3.3 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.3 million in Q4 2025 and bottomed at -$5.3 million in Q2 2025.
- The 5-year median for Change in Accured Expenses is -$4000.0 (2024), against an average of -$84294.1.
- The widest annual swing landed in 2025, when Change in Accured Expenses jumped 813.17%; it then slumped 90825.0% in 2026.
- Tracing MXCT's Change in Accured Expenses over 5 years: stood at -$285100.0 in 2022, then jumped by 707.51% to $1.7 million in 2023, then slumped by 126.73% to -$463000.0 in 2024, then jumped by 813.17% to $3.3 million in 2025, then sank by 210.15% to -$3.6 million in 2026.
- Per Business Quant, the three latest MXCT Change in Accured Expenses figures stand at -$3.6 million (Q1 2026), $3.3 million (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | -3.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.64 Mn |
| Mar 31, 2026 | -3.64 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Mar 31, 2025 | -4,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -463,000.00 |
| Dec 31, 2024 | -463,000.00 |
| Sep 30, 2024 | 2.08 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | -3.49 Mn |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 1.73 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | -1.03 Mn |
| Jun 30, 2023 | -1.03 Mn |
| Mar 31, 2023 | -13,000.00 |
| Mar 31, 2023 | -13,000.00 |
| Dec 31, 2022 | -285,100.00 |
| Dec 31, 2022 | -285,100.00 |
| Sep 30, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.21 Mn |
| Jun 30, 2022 | 93,300.00 |
| Jun 30, 2022 | 93,300.00 |
| Mar 31, 2022 | -150,500.00 |
| Mar 31, 2022 | -150,500.00 |
| Dec 31, 2021 | -46,400.00 |
| Dec 31, 2021 | -46,400.00 |
| Sep 30, 2021 | 965,300.00 |
| Sep 30, 2021 | 965,300.00 |
| Jun 30, 2021 | 427,900.00 |
| Jun 30, 2021 | 427,900.00 |
| Mar 31, 2021 | -1.42 Mn |
| Mar 31, 2021 | -1.42 Mn |
| Dec 31, 2020 | -213,000.00 |
| Dec 31, 2020 | -213,000.00 |
| Sep 30, 2020 | 2.49 Mn |
| Sep 30, 2020 | 2.49 Mn |